Spironolactone Tablet, Film Coated
Product Images NDC 51655-636

4 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 51655-636). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)
Chemical structure of spironolactone, depicting its molecular framework with steroid rings, ketone groups, and a thioacetate functional group. The diagram illustrates the connectivity of atoms within the spironolactone molecule.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)
A Kaplan-Meier survival probability chart comparing spironolactone and placebo over 42 months. The x-axis shows time in months and the y-axis shows survival probability. Two survival curves are plotted, one for spironolactone (n=822) and one for placebo (n=841), with a log-rank p-value less than 0.001 indicating a statistically significant difference.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)
A forest plot displaying hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups comparing spironolactone and placebo effectiveness. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium level, digoxin use, ACE inhibitor use, and beta blocker use, with numerical data for sample sizes and percentages shown.*
FDA Label Image

Label (51655 636 52 Rev A 06 23 Nhc)

Label (51655 636 52   Rev A 06 23 Nhc)
Label for spironolactone tablets USP 25 mg, oral film-coated tablets. The package contains 30 tablets. The label includes storage instructions, a warning to keep out of reach of children, and information indicating it is a prescription drug. The labeler is Northwind Health Company, LLC, with product NDC 51655-636.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.